.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Managing recovery requires effective strategies, and using naltrexone for OUD relapse prevention is a primary clinical option. However, clinicians often face hurdles with patient adherence and treatment initiation. A comprehensive meta-analysis recently evaluated data from over 140,000 participants to identify the factors influencing these outcomes.
The study found that initiation rates vary significantly depending on the formulation. Patients initiated oral naltrexone at a rate of 60.3%, whereas only 18.2% initiated depot formulations. Notably, patients were more likely to start oral treatment when it was the only pharmacotherapy offered. This suggests that offering choices might paradoxically lower the uptake of specific treatments like naltrexone. Consequently, practitioners should carefully frame treatment options during the shared decision-making process.
Discontinuation remains a major barrier to long-term recovery. For oral naltrexone, half of the patients stopped within the first month. By the sixth month, this figure rose to 71%. Although depot formulations showed better retention initially, discontinuation still reached 60% by six months. Therefore, the first few months of treatment represent a critical window for clinical intervention. Clinicians must actively monitor patients during this period to improve long-term outcomes.
Supervised administration significantly improves retention rates for oral medication. The meta-analysis demonstrated that supervised dosing reduced discontinuation at three and six months. Specifically, supervision helps maintain the treatment bridge during vulnerable recovery phases. Therefore, incorporating family or clinical supervision can enhance the effectiveness of naltrexone for OUD relapse prevention programs. In addition, providing continuous support and counseling can further mitigate the risk of early dropout.
Many patients stop naltrexone due to a lack of immediate reinforcement, as it is an antagonist rather than an agonist. Early discontinuation is common, especially within the first month of treatment, often due to cravings or side effects during the post-withdrawal phase.
Yes, depot (injectable) formulations generally show lower discontinuation rates in the first month compared to oral naltrexone. However, both forms see significant dropout rates by the six-month mark, highlighting the need for ongoing behavioral support.
Supervised administration significantly reduces discontinuation rates. By involving a healthcare provider or a family member in the daily dosing process, patients are more likely to remain compliant, especially at the 3 and 6-month milestones.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A recent meta-analysis examine initiation and discontinuation rates of naltrexone for opioid use disorder. It highlights high early dropout rates and the significant impact of supervised administration on treatment retention for patients who have completed withdrawal.
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
